[Secondary osteoporosis UPDATE. Rheumatoid arthritis and bone damage: trends in treatment].
Tanaka, Yoshiya
[Secondary osteoporosis UPDATE. Rheumatoid arthritis and bone damage: trends in treatment]. [electronic resource] - Clinical calcium May 2010 - 735-42 p. digital
Publication Type: English Abstract; Journal Article; Review
0917-5857
CliCa1005735742 doi
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Arthritis, Rheumatoid--complications
Bone Density Conservation Agents--therapeutic use
Bone Remodeling
Denosumab
Diphosphonates--therapeutic use
Glucocorticoids--adverse effects
Humans
Methotrexate--therapeutic use
Osteoclasts--physiology
Osteoporosis--drug therapy
RANK Ligand--therapeutic use
Synovial Membrane
Tumor Necrosis Factor-alpha--antagonists & inhibitors
[Secondary osteoporosis UPDATE. Rheumatoid arthritis and bone damage: trends in treatment]. [electronic resource] - Clinical calcium May 2010 - 735-42 p. digital
Publication Type: English Abstract; Journal Article; Review
0917-5857
CliCa1005735742 doi
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Arthritis, Rheumatoid--complications
Bone Density Conservation Agents--therapeutic use
Bone Remodeling
Denosumab
Diphosphonates--therapeutic use
Glucocorticoids--adverse effects
Humans
Methotrexate--therapeutic use
Osteoclasts--physiology
Osteoporosis--drug therapy
RANK Ligand--therapeutic use
Synovial Membrane
Tumor Necrosis Factor-alpha--antagonists & inhibitors